Response and survival outcomes
death
DISEASE, EVENT, BEST
Best radiographic response per RECIST 1.1 following interim contrast CT scans before resection was partial response in 4 of 19 (21%, 95% CI 6%–46%) patients, but stable disease was the more common finding (Table Treatment response.The median duration of follow‐up for all 19 patients was 21.6 (95% CI 13.5–NA) months, with 15 patients having reached an event of interest (e.g., progression and death) at the time of data cutoff. Four remained alive and free of disease at the data cutoff date. The median PFS was 13.5 (95% CI 10.8–NA) months, where the 12‐month PFS was 58% (95% CI 39%–85%; Figure Progression‐free survival analysis from neoadjuvant therapy initiation.Overall survival analysis from neoadjuvant therapy initiation.